Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib

oleh: Alexander P. Bye, Neline Kriek, Tanya Sage, Suzannah J. Rawlings, Catherine Prodger, Murali Kesavan, Charlotte Lees, Stephen Booth, Louise G. Cowen, Kirsty Shefferd, Michael J. Desborough, Jonathan M. Gibbins, Toby A. Eyre

Format: Article
Diterbitkan: Ferrata Storti Foundation 2022-12-01

Deskripsi

No description available for this item.